Cover Page

Cite item


Phylogeographical and philodinamic studies have shown that the hepatitis C virus began to circulate in the human population about 500–2000 years ago on the A frican continent and only in the 20th century, this virus received the ubiquitary distribution. According to WHO in the world more than 71 million people are chronically infected by the hepatitis C virus, more than half of them live in A frica and South-East Asia. At the same time, the actual prevalence of hepatitis C in most countries of sub-Saharan A frica, including the Republic of Guinea, remains poorly understood.

The aim of this study was to evaluate the occurrence of serological and molecular markers of hepatitis C on a random small selection of blood samples obtained from healthy adults of the Republic of Guinea.

Materials and methods. Serum and plasma blood samples obtained from thirty one healthy adults of 24–71 years old of the Republic of Guinea were examined. Blood samples were collected in 2015–2016 years. The serum samples were analyzed for the presence of total anti-HCV (IgG+IgM),  of specific antibodies to the core, the NS3, the NS4 and the NS5B HCV proteins, of core antigene with “DS-ELISA-ANTI-HCV-GM”, “DS-ELISA-ANTI-HCV-SPEKTRE-GM”, “DS-ELISA-HCV-Ag” detection kits (RPC “Diagnostic Systems”, Russia), respectively. RNA HCV were detected by RT-PCR with detection kit “A mpliSens HCV-FRT” (CRIE, Moscow) and by nested-PCR using the primers from 5’UTR region. HCV genotypes were determined by RT-PCR  with detection kit “A mpliSens HCV-genotype FRT” (CRIE, Moscow) and by phylogenetic analysis based on the 5’UTR region.

Results and discussion. In this pilot study, the presence of HCV markers was confirmed in 3 (9.68%, 95% CI 3.35–24.90) of 31 examined persons. Two of them had RNA HCV. Based on the phylogenetic analysis of the 5’UTR region of the HCV genome, the isolate obtained from person No. 5 belonged to genotype 1, and the isolate obtained from person No. 6 belonged to genotype 2. The obtained results together with the analyzed literature data indicate a significant burden of hepatitis C in the Republic of Guinea, and also indicate the need to develop both an algorithm of diagnostic criteria and the improvement of diagnostic test systems for mass screening of the A frican population in order to establish the proportion of persons involved in epidemic process.

About the authors

O. V. Kalinina

St. Petersburg Pasteur Institute

Author for correspondence.

Olga V. Kalinina - PhD, MD (Biology), Leading Researcher, Laboratory of Molecular Evolution and Evolutionary Genetics.

197101, St. Petersburg, Mira str., 14, Phone: +7 (812) 233-29-41 (office); +7 921 746-39-07 (mobile)

Russian Federation

E. V. Lichnaia

St. Petersburg Pasteur Institute


Junior Researcher, Laboratory of Viral Hepatitis

Russian Federation

M. Y. Boiro

Institute of Applied Biology in Guinea


Professor, General Director, Institute of Applied Biology in Guinea.

Kindia Guinea

Areg A. Totolian

St. Petersburg Pasteur Institute


RAS Full Member, PhD, MD (Medicine), Professor, Head of the Laboratory of Molecular Immunology, Director.

St. Petersburg 

Russian Federation


  1. Жебрун А.Б., Калинина О.В. Вирусный гепатит С: эволюция эпидемического процесса, эволюция вируса // Журнал микробиологии, эпидемиологии и иммунобиологии. 2016. № 1. С. 102–112. [Zhebrun A.B., Kalinina O.V. Viral hepatitis C: evolution of the epidemiologic process, evolution of the virus. Zhurnal mikrobiologii, epidemiologii i immunobiologii = Journal of Microbiology, Epidemiology and Immunobiology, 2016, no. 1, pp. 102–112. (In Russ.)]
  2. Калинина О.В. Вирус гепатита С: механизмы изменчивости, к лассификация, эволюция // Вопросы вирусологии. 2015. T. 60, № 5. C. 5–10. [Kalinina O.V. Hepatitis C virus: variability mechanisms, classification, evolution. Voprosy virusologii = Problems of Virology, 2015, vol. 60, no. 5, pp. 5–10. (In Russ.)]
  3. Bah A.O., Lamine C., Balde M.C., Bah M.L., Rostaing L. Epidemiology of chronic kidney diseases in the Republic of Guinea; future dialysis needs. J. Nephropathol., 2015, vol. 4, no. 4, pp. 127–133. doi: 10.12860/jnp.2015.24
  4. Daw M.A., El-Bouzedi A., Ahmed M.O., Dau A.A, Agnan M.M. In association with the Libyan Study Group of Hepatitis & HIV. Epidemiology of hepatitis C virus and genotype distribution in immigrants crossing to Europe from North and sub-Saharan Africa. Travel Med. Infect. Dis., 2016, vol. 14, no. 5, pp. 517–526. doi: 10.1016/j.tmaid.2016.05.020
  5. Forbi J.C., Purdy M.A., Campo D.S., Vaughan G., Dimitrova Z.E., Ganova-Raeva L.M., Xia G.L., Khudyakov Y.E. Epidemic history of hepatitis C virus infection in two remote communities in Nigeria, West Africa. J. Gen. Virol., 2012, vol. 93, pt. 7, pp. 1410 –1421. doi: 10.1099/vir.0.042184-0
  6. Gower E., Estes C., Blach S., Razavi-Shearer K., Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J. Hepatol., 2014, vol. 1, suppl. 1, pp. S45–S57. doi: 10.1016/j.jhep.2014.07.027
  7. Kalinina O., Norder H., Vetrov T., Zhdanov K., Barzunova M., Plotnikova V., Mukomolov S., Magnius L. Shift in predominating subtype of HCV from 1b to 3a in St. Petersburg mediated by increase in injecting drug use. J. Med. Virol., 2001, vol. 65, pp. 517–524. doi: 10.1002/jmv.2066
  8. Markov P.V., Pepin J., Frost E., Deslandes S., Labbe A.-C., Pybus O.G. Phylogeography and molecular epidemiology of hepatitis C virus genotype 2 in Africa. J. Gen. Virol., 2009, vol. 90, no. 9, pp. 2086–2096. doi: 10.1099/vir.0.011569-0
  9. Messina J.P., Humphreys I., Flaxman A., Brown A., Cooke G.S., Pybus O.G., Barnes E. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology, 2015, vol. 61, no. 1, pp. 77–87. doi: 10.1002/hep.27259
  10. Mora N., Adams W.H., Kliethermes S., Dugas L., Balasubramanian N., Sandhu J., Nde H., Small C., Jose J., Scaglione S., Layden J.E. A Synthesis of Hepatitis C prevalence estimates in Sub-Saharan Africa: 2000–2013. BMC Infect. Dis., 2016, vol. 16, pp. 283. doi: 10.1186/s12879-016-1584-1
  11. Mullis C.E., Laeyendecker O., Reynolds S.J., Ocama P., Quinn J., Boaz I., Gray R.H., Kirk G.D., Thomas D.L., Quinn T.C., Stabinski L. High frequency of false-positive hepatitis C virus enzyme-linked immunosorbent assay in Rakai, Uganda. Clin. Infect. Dis., 2013, vol. 57, no. 12, pp. 1747–1750. doi: 10.1093/cid/cit602
  12. Njouom R., Frost E., Deslandes S., Mamadou-Yaya F., Labbé A.C., Pouillot R., Mbélesso P., Mbadingai S., Rousset D., Pépin J. Predominance of hepatitis C virus genotype 4 infection and rapid transmission between 1935 and 1965 in the Central African Republic. J. Gen. Virol., 2009, vol. 90, no. 10, pp. 2452–2456. doi: 10.1099/vir.0.011981-0
  13. Onakewhor J.U., Okonofua F.E. Seroprevalence of Hepatitis C viral antibodies in pregnancy in a tertiary health facility in Nigeria. Niger. J. Clin. Pract., 2009, vol. 12, no. 1, pp. 65–73.
  14. Purdy M.A., Forbi J.C., Sue A., Layden J.E., Switzer W.M., Opare-Sem O.K., Phillips R.O., Khudyakov Y.E. A re-evaluation of the origin of hepatitis C virus genotype 2 in West Africa. J. Gen. Virol., 2015, vol. 96, no. 8, pp. 2157–2164. doi: 10.1099/vir.0.000153
  15. Ruggieri A., Argentini C., Kouruma F., Chionne P., D’Ugo E., Spada E., Dettori S., Sabbatani S., Rapicetta M. Heterogeneity of hepatitis C virus genotype 2 variants in West Central Africa (Guinea Conakry). J. Gen. Virol., 1996, vol. 77, pp. 2073–2076. doi: 10.1099/0022-1317-77-9-2073
  16. Tagny C.T., Mbanya D., Murphy E.L., Lefrère J.J., Laperche S. Screening for hepatitis C virus infection in a high prevalence country by an antigen/antibody combination assay versus a rapid test. J. Virol. Methods, 2014, vol. 199, pp. 119–123. doi: 10.1016/j.jviromet.2014.01.002
  17. World Health Organization. Hepatitis C. WHO. Fact Sheet, April 2017.

Copyright (c) 2017 Kalinina O.V., Lichnaia E.V., Boiro M.Y., Totolian A.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 64788 от 02.02.2016.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies